Current Drug Research Reviews

(Formerly Current Drug Abuse Reviews)

ISSN (Print): 2589-9775
ISSN (Online): 2589-9783

Volume 14, Issue 3, 2022

This journal supports open access

Back Journal Home
Topic(s) Covered

1 Topic(s)

View


Aims & Scope

Current Drug Research Reviews publishes research articles, review article and clinical studies on the design and development of new drugs, including drug targeting, medicinal chemistry, in-silico drug design, combinatorial chemistry, meta-analyses, drug abuse and addiction, drug-drug interactions and enzyme kinetics; species scaling and extrapolations; drug transporters; target organ toxicity and inter-individual variability in drug exposure-response; extrahepatic metabolism; bio-activation, reactive metabolites, high-throughput screening, drug targets and structure-activity relationships.

The journal aims to cover the latest developments in all important aspects of drug design, delivery, development and research.

Current Drug Research Reviews is essential for all pharmaceutical scientists involved in drug design and development.

Abstracted/Indexed in


Cabells Journalytics, Chemical Abstracts Service/SciFinder, ChemWeb, CNKI Scholar, Dimensions, EBSCO, EMBASE, EMCare, Genamics JournalSeek, Google Scholar, J-Gate, JournalTOCs, MediaFinder®-Standard Periodical Directory, MEDLINE/PubMed, Open Abstracts (I4OA), PubsHub, Scilit, Scopus, Suweco CZ, TOC Premier, and Ulrich's Periodicals Directory.

COPE COMPLIANT
Special Offers

Quick processing and publication of the submitted papers. The manuscript will be published online within 20 days of final acceptance.

30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published.
Multiple issue copies at discounted rates.

© 2022 Bentham Science Publishers | Privacy Policy